{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-415.12",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 415.12 - Quality of care",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 415.12 - Quality of care\n\nState Regulations\n\nEach resident shall receive and the facility shall\nprovide the necessary care and services to attain or maintain the highest\npracticable physical, mental and psychosocial well-being, in accordance with\nthe comprehensive assessment and plan of care subject to the resident's right\nof self-determination. (a) Activities\nof daily living. Based on the comprehensive assessment of a resident, the\nfacility shall ensure that: (1)\na resident's\nabilities in activities of daily living do not diminish unless circumstances of\nthe individual's clinical condition demonstrate that diminution was\nunavoidable. This includes the resident's ability to: (i) bathe, dress and groom; (ii)\ntransfer and ambulate; (iii)\ntoilet; (iv)\neat; and\n(v) use speech, language or other functional\ncommunication systems; (2)\na resident is given the appropriate\ntreatment and services to maintain or improve his or her abilities specified in\nparagraph (1) of this subdivision; and\n(3)\na resident who is unable to carry out\nactivities of daily living receives the necessary services to maintain good\nnutrition, grooming, and personal and oral hygiene. (b) Vision and hearing. To ensure that\nresidents receive proper treatment and assistive devices to maintain vision and\nhearing abilities, the facility shall, if necessary, assist the resident: (1)\nin making appointments; (2)\nby arranging for transportation to and\nfrom the office of a medical practitioner specializing in the treatment of\nvision or hearing impairment or the office of a professional specializing in\nthe provision of vision or hearing assistive devices if such services are not\nprovided on-site; and\n(3)\nby\npromoting the safekeeping, maintenance, and use of vision or hearing assistive\ndevices which the resident needs. (c) Pressure sores. Based on the\ncomprehensive assessment of a resident, the facility shall ensure that: (1)\na resident who enters the facility\nwithout pressure sores does not develop pressure sores unless the individual's\nclinical condition demonstrates that they were unavoidable despite every\nreasonable effort to prevent them; and\n(2)\na resident having pressure sores receives\nnecessary treatment and services to promote healing, prevent infection and\nprevent new sores from developing. (d) Urinary incontinence. Based on the\nresident's comprehensive assessment, the facility shall ensure that: (1)\na resident who is incontinent of bladder\nreceives the appropriate treatment and services to prevent urinary tract\ninfections and to restore as much normal bladder function as possible; and\n(2)\na resident who enters the\nfacility without an indwelling catheter is not catheterized unless the\nresident's clinical condition demonstrates that catheterization was\nnecessary. (e) Range of\nmotion. Based on the comprehensive assessment of a resident, the facility shall\nensure that: (1)\na resident who enters the\nfacility without a limited range of motion does not experience reduction in\nrange of motion unless the resident's clinical condition demonstrates that a\nreduction in range of motion is unavoidable; and\n(2)\na resident with a limited range of motion\nreceives appropriate treatment and services to increase range of motion and/or\nto prevent further decrease in range of motion. (f) Mental and psychosocial functioning. Based on the comprehensive assessment of a resident, the facility shall ensure\nthat: (1)\na resident who displays mental or\npsychosocial adjustment difficulty receives appropriate treatment and services\nto correct the assessed problem; and\n(2)\na resident whose assessment did not\nreveal a psychosocial adjustment difficulty does not display a pattern of\ndecreased social interaction and/or increased withdrawn, angry, or depressive\nbehaviors, unless the resident's clinical condition demonstrates that such a\npattern was unavoidable. (g) Enteral feeding tubes. (1)\n\nBased on the comprehensive assessment of\na resident, the facility shall ensure that a resident who has been able to eat\nalone or with assistance is not fed by an enteral feeding tube unless the\nresident's clinical condition demonstrates that use of such a tube was\nunavoidable. (2)\nA resident who is\nfed by an enteral feeding tube shall receive the appropriate treatment and\nservices to prevent aspiration pneumonia, diarrhea, significant regurgitation, vomiting, dehydration, metabolic abnormalities, and nasal-pharyngeal ulcers and\nto restore, if possible, normal feeding function. (3)\n\nFollowing consideration of possible\nalternatives for short-term nutritional therapy, nasogastric tubes and feeding\nformulations may be used for feeding purposes when determined clinically\nappropriate by the attending physician and interdisciplinary care team which\nincludes a health care professional with training in diagnosis and management\nof swallowing disorders. Nasogastric tube feedings shall be used to promote a\ntherapeutic program to maintain adequate nutrition and hydration and include a\nplan to help the resident develop or regain eating skills. (4)\n\nResidents receiving nasogastric tube\nfeedings shall be reassessed at a minimum by the registered professional nurse, social worker, and dietitian as needed, but no less than once every six weeks, for the ability to return to normal feeding function. If the nasogastric\nfeeding is continued, the reasons for continuation shall be documented in the\nresident's clinical record. If nasogastric feedings are to be continued longer\nthan 95 days, permanent enteral feeding procedures such as surgical gastrostomy\nor jejunostomy shall be considered. (5)\n\nNasogastric tube feeding formulations\nshall be given in accordance with the manufacturer's instructions or at a rate\nappropriate to the physical size of the resident and the amount of fluid and\nnutrients necessary to meet the assessed caloric and fluid needs of the\nresident. (6)\n\nTo minimize resident\ndiscomfort, nasogastric tubes used for resident feeding purposes shall: (i) be the smallest gauge appropriate for the\npatient and shall not exceed 3.96 millimeters (#12 French) in outside diameter\nunless medically indicated; (ii)\nbe\nmade of a soft, flexible material such as medical grade polyurethane or\nsilicone; and\n(iii)\nbe specifically\nmanufactured for nasogastric feeding purposes. (7)\n\nThe facility shall develop and follow\npolicies and procedures for nasogastric tube feedings which are written in\naccordance with prevailing standards of professional practice and in\nconsultation with the medical, nursing, dietary and pharmacy services of the\nfacility. Medical practitioners shall be informed of such policies and\nprocedures governing the use of nasogastric tubes for resident feeding. The\npolicies and procedures shall address as a minimum: (i) types and sizes of nasogastric tubes and\nthe various types of feeding formulations available at the facility; (ii)\nthe need to assess each resident's\nclinical and nutritional status to determine the size of the nasogastric tube\nand type of feeding appropriate for that individual; (iii)\nstandard techniques for inserting a\nnasogastric tube and confirming the correct placement of the tube; (iv)\nprocedures for administering nasogastric\nfeedings including positioning the resident and the need for resident\nobservation and monitoring before, during and following the feeding; and\n(v) infection control policies\nrelated to tube feedings. (h) Accidents. The facility shall ensure\nthat: (1)\nthe resident environment remains as\nfree of accident hazards as is possible; and\n(2)\neach resident receives adequate\nsupervision and assistive devices to prevent accidents. (i) Nutrition. Based on a resident's\ncomprehensive assessment, the facility shall ensure that a resident: (1)\nmaintains acceptable parameters of\nnutritional status, such as body weight and protein levels, unless the\nresident's clinical condition demonstrates that this is not possible; and\n(2)\nreceives a therapeutic diet\nwhen there is a nutritional problem. (j) Hydration. The facility shall provide\neach resident with sufficient fluid intake to maintain proper hydration and\nhealth. (k) Special needs. The\nfacility shall ensure that residents receive proper treatment and care for the\nfollowing special services: (1)\ninjections; (2)\nparenteral and\nenteral fluids; (3)\ncolostomy, ureterostomy or ileostomy care; (4)\ntracheostomy care; (5)\ntracheal\nsuctioning; (6)\nrespiratory\ncare; (7)\npodiatric care; and\n(8)\nprostheses. (l) Drug therapy. (1)\n\nUnnecessary drugs. Each resident's drug\nregimen shall include only those medications prescribed to treat a specific\ndocumented illness or condition and not otherwise contraindicated for a given\nresident. The drug regimen shall be monitored for evidence of both adverse\nactions and therapeutic effect. Dose changes or discontinuation of the drug\nmust be made if the drug is ineffective and/or is causing disabling or harmful\nside effects and/or the condition for which it was prescribed has\nresolved. (2)\n\nPsychotropic drugs. Based on a comprehensive assessment of a resident and consistent with the\nprovisions of subdivision (a) of section\n415.4\nof this Part, the facility\nshall ensure that: (i) the use of\npsychotropic drugs shall: (a) meet all\nconditions of paragraph (1) of this subdivision; (b) be ordered by a physician who, in\naccordance with generally accepted standards of care and services, specifies\nthe problem for which the drug is prescribed; (c) be used, except in emergencies, only as\nan integral part of a resident's comprehensive care plan and only after\nalternative methods for treating the condition or symptoms have been tried and\nhave failed; and\n(d) be\ndiscontinued if harmful effects of the medication outweigh the beneficial\neffects of the drug. (ii)\nresidents who use psychotropic drugs\nreceive gradual dose reductions and behavioral interventions, unless clinically\ncontraindicated, in an effort to discontinue these drugs and assist the\nresident to attain and maintain optimum physical and emotional\nfunctioning. (m) Medication errors. The facility shall\nensure that: (1)\nit is free of medication\nerror rates of five percent or greater; and\n(2)\nresidents are free of any significant\nmedication errors. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n415.12\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 44295
}